← Open Payments lookup

MONALISA CHURCHMAN: Open Payments

NPI 1043080104 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$856 in 62 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $867 · 2025 $856

Food & beverage: $856
CompanyPaymentsAmount
ABBVIE INC.12$276
Supernus Pharmaceuticals, Inc.30$179
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$82
Otsuka America Pharmaceutical, Inc.4$75
Lundbeck LLC3$60
Neurocrine BioSciences, Inc.2$60
Teva Pharmaceuticals USA, Inc.3$56
Collegium Pharmaceutical, Inc.1$18
E.R. Squibb & Sons, L.L.C.1$17
Takeda Pharmaceuticals U.S.A., Inc.1$16

Products named: VRAYLAR, Qelbree, REXULTI, CAPLYTA, INGREZZA, AUSTEDO XR, Jornay PM, COBENFY.

Industry payments across TX — which companies pay providers there.